| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
COLL sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 197.9K | - | - | |
| CFO | 147.3K | - | - | |
| Dir | 112.5K | $1.85M | - | |
| VP | 90.7K | - | - | |
| Dir | 84.0K | $2.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Freund John Gordon79 | Director | Sell | 20 | $34.05 | $681.00 | - | -16.6% | - | |
| May 15, 2026 | Freund John Gordon79 | Director | Sale+OE | 4,127 | $34.54 | $142,546.58 | -4.7% | -16.7% | - | |
| May 13, 2026 | Lurker Nancy77 | Director | Sell | 4,500 | $35.97 | $161,860.95 | -20.0% | -25.5% | - | |
| May 11, 2026 | Bohlin Garen G | Director | Sale+OE | 8,700 | $37.18 | $323,491.23 | -12.3% | -24.0% | - | |
| Mar 18, 2026 | Dieter David | EVP &General Counsel | Sell | 13,976 | $34.92 | $488,099.22 | -15.4% | -0.4% | - | |
| Mar 9, 2026 | Dieter David | EVP &General Counsel | Sell | 6,224 | $36.65 | $228,109.60 | -6.4% | -10.7% | - | |
| Mar 3, 2026 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 49,976 | $40.41 | $2,019,436.72 | -41.0% | -20.6% | - | |
| Dec 8, 2025 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sale+OE | 17,600 | $48.17 | $847,855.20 | -14.5% | -22.2% | - | |
| Dec 5, 2025 | Balice-Gordon Rita J. | Director | Sell | 3,650 | $47.03 | $171,673.37 | -6.5% | -22.1% | - | |
| Nov 12, 2025 | Fallon John A. | Director | Sale+OE | 34,853 | $47.21 | $1,645,535.60 | -35.0% | -1.3% | - |